European initiative seeks EU approval for psychedelic substances in therapy, citing expert support.
π Read the article on derstandard.at
[This is an automatically generated summary, for reference only]
An European initiative, Psychedelicare, is pushing for the EU Commission to allow psychedelics for therapeutic use, seeking one million endorsements from experts who believe psychedelic-assisted therapy could be a game changer. While medical use of substances like LSD, psilocybin, and MDMA is permitted in countries such as the US, Canada, Australia, and Switzerland, the EU remains cautious on this matter.
